Changes of sinusoidal basement membrane collagens in early hepatic fibrosis induced with CC14 in cynomolgus monkeys

Pathology

Volumn 31, Issue 1, 1999, Pages 29-35

  Yoshida, Tsuyoshi ^a   Adachi, Eijiro ^b   Nigi, Hideo ^c   Fujii, Seishero ^a   Yanagi, Mitsuo ^a  

^a SHISEIDO RESEARCH CENTER   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

Basement membrane; Collagen; Fibrosis; Immunohistochemistry; Liver; Sinusoid

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CHOLINESTERASE; COLLAGEN TYPE 4; HYALURONIC ACID; MONOCLONAL ANTIBODY;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BASEMENT MEMBRANE; BLOOD LEVEL; CHOLINESTERASE BLOOD LEVEL; CONNECTIVE TISSUE; DISULFIDE BOND; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER SINUSOID; MALE; MONKEY; NONHUMAN;

EID: 0033048426     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/003130299105494     Document Type: Article

References (37)

1. Popper H. Hepatic fibrosis and collagen metabolism in the liver. In: Popper H, Becker K, editors. Collagen metabolism in the liver. New York: Stratton Intercontinental, 1975; 1-14.
2. Nakabayashi H, Takamatsu S, Tsujii H, Okamoto Y, Nakano H, Yamada E, Ichijima K. Collagen content of liver biopsy specimens in patients with chronic hepatitis. Int Hepatol Commun 1996; 4: 311-5.
3. Inuzuka S, Ueno T, Tanikawa K. Fibrogenesis in acute liver injuries. Pathol Res Pract 1994; 190: 903-9.
4. Bedossa P, Paradis V. Transforming growth factor (TGF-Β): a key-role in liver fibrogenesis. J Hepatol 1995; 22: 37-42.
5. Inagaki Y, Truter S, Greenwel P, Rojkind M, Unoura M, Kobayashi K, et al. Regulation of the α2(I) collagen gene transcription in fat-storing cells derived from a cirrhotic liver. Hepatology 1995; 22: 573-9.
6. Davis BH, Kresina TF. Hepatic fibrogenesis. Clin Lab Med 1996; 16: 361-75.
7. Alcolado R, Arthur MJP, Iredale JP. Pathogenesis of liver fibrosis. Clin Sci 1997; 92: 103-12.
8. Kino J, Adachi E, Yoshida T, Asamatsu C, Nakajima K, Yamamoto K, et al. A novel chain of basement membrane-associated collagen as revealed by biochemical and immunohistochemical characterization of the epitope recognized by a monoclonal antibody against human placenta basement membrane collagen. Am J Pathol 1991; 138: 911-20.
9. Adachi E, Kino J, Hayashi T, Sato Y, Hashimoto PH. The effect of fixative and paraffin embedding on the histochemical reactivity of a monoclonal antibody against human type IV collagen (JK-199). Arch Histol Cytol 1989; 52: 477-83.
10. Iwata M, Imamura Y, Sasaki T, Hayashi T. Evidence for a short form of α1(IV) as a major polypeptide in bovine lens capsule. J Biochem 1995; 117: 1298-304.
11. Iwata M, Sado Y, Sasaki T, Imamura Y, Ninomiya Y, Hayashi T. The 160K α1(IV) chain, a short form of a type IV collagen polypeptide, of bovine lens capsule retains the NC1 domain. J Biochem 1996; 120: 133-7.
12. Amano S, Ohta Y, Fujiwara K, Miyake K, Fujii S, Yoshida T, et al. Improvement of the sandwich ELISA for the determination of basement membrane collagen complex in sera of patients with chronic liver disease by utilizing the chaotropic ion, NaSCN. Int Hepatol Commun 1995; 4: 1-8.
13. Yoshida T, Matsubara O, Adachi E, Kino J, Asamatsu C, Takeda Y, et al. Increased deposition and altered distribution of basement membrane-related collagens in human fibrotic or cirrhotic liver. Connect Tissue 1997; 29: 189-98.
14. Saga K, Sato N, Amemiya K. Quantitative method using carmine dye for measuring the volume of blood vessels in the liver and capillaries developing effect of pronase in experimentally chronic liver lesion induced by D-galactosamine plus carbon tetrachloride. Jpn Pharmacol Ther 1988; 16: 67-70.
15. Kino J, Adachi E, Yoshida T, Nakajima K, Hayashi T. Characterization of a monoclonal antibody against human type IV collagen by immunoelectroblotting, antibody-coupled affinity chromatography, and immunohistochemical localization. J Biochem 1988; 103: 829-35.
16. Yoshida T, Adachi E, Matsubara O, Kino J, Asamatsu C, Sato Y, et al. Semiquantitative analysis of the effects of fixation and paraffin embedding on immunoreactivity of renal basement membranes to a monoclonal antibody against type IV collagen. Arch Histol Cytol 1992; 55: 497-502.
17. Clément B, Loréal O, Rescan P-Y, Levavasseur F, Diakonova M, Rissel M, et al. Cellular origin of the hepatic extracellular matrix. In: Gressner AM, Ramadori G, editors. Molecular and cell biology of liver fibrogenesis. Dordrecht: Kluwer Academic Publishers, 1992; 85-98.
18. Levavasseur F, Loréal O, Liétard J, Théret N, L'helgoualc'h A, Guillouzo A, et al. Basement membrane gene expression in the liver. J Hepatology 1995; 22: 10-9.
19. Friedmann SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. New Engl J Med 1993; 328: 1828-35.
20. Rojkind M, Ponce-Noyola P. The extracellular matrix of the liver. Collagen Rel Res 1982; 2: 151-75.
21. Bissell DM, Arenson DM, Maher JJ, Roll FJ. Support of cultured hepatocytes by a laminin-rich gel. J Clin Invest 1987; 79: 801-12.
22. McGuire RF, Bissell DM, Boyles J, Roll FJ. Role of extracellular matrix in regulation fenestrations of sinusoidal endothelial cells isolated from normal rat liver. Hepatology 1992; 15: 989-97.
23. Okazaki I, Maruyama K. Collagenase activity in experimental hepatic fibrosis. Nature 1974; 252: 49-50.
24. Ehrinpreis MN, Giambrone M-A, Rojkind M. Liver proline oxidase activity and collagen synthesis in rats with cirrhosis induced by carbon tetrachloride. Biochim Biophy Acta 1980; 629: 184-93.
25. Johnson SJ. Extracellular matrix proteins and hepatic fibrosis. Hepato-Gastroenterology 1996; 43: 44-55.
26. 4-induced liver fibrosis. Hepatology 1997; 26: 611-7.
27. Arthur MJP. Role of Ito cells in the degradation of matrix in liver. J Gastroenterol Hepatol 1995; 10: s57-s62.
28. Gressner AM, Bachem MG. Molecular mechanisms of liver fibrogenesis - a homage to the role of activated fat-storming cells. Digestion 1995; 56: 335-46.
29. Iredale JP. Matrix turnover in fibrogenesis. Hepato-Gastroenterology 1996; 43: 56-71.
30. Yamada M, Fukuda Y, Nakano I, Katano Y, Takamatsu J, Hayakawa T. Serum hyaluronan as a marker of liver fibrosis in hemophiliacs with hepatitis C virus-associated chronic liver disease. Acta Haematol 1998; 99: 212-6.
31. Wong VS, Hughes V, Trull A, Wight DGD, Petrik J, Alexander GJM Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepat 1998; 5: 187-92.
32. Schuppan D, Stölzel U, Oesterling C, Somasundaram R. Serum assys for liver fibrosis. J Hepatol 1995; 22: 82-8.
33. 4-induced cirrhosis. Biochim Biophys Acta 1980; 629: 490-8.
34. 4-induced liver fibrogenesis. J Hepatol 1994; 21: 1149-50.
35. Rojkind M, Dunn MA. Hepatic fibrosis. Gastroenterology 1979; 76: 849-63.
36. Abdel-Aziz G, Lebeau G, Rescan P-Y, Clément B, Rissel M, Deugnier Y, et al. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. Am J Pathol 1990; 137: 1333-42.
37. Hutterer F, Eisenstadt M, Rubin E. Turnover of hepatic collagen in reversible and irreversible fibrosis. Experientia 1970; 26: 244-5.